Literature DB >> 2642739

Identification of a recurring translocation site involving chromosome 6 in human malignant melanoma.

J M Trent1, F H Thompson, F L Meyskens.   

Abstract

The recognition of recurring sites of chromosome change in human cancers has pinpointed the location in the genome of several important growth-regulatory sequences (e.g., cellular oncogenes). This report details the finding of a recurring translocation site involving the long arm of chromosome 6 (6q) in malignant melanoma. We have observed a translocation (t) between chromosomes 1 and 6 in five different cases of malignant metastatic melanoma. All five melanomas evidencing t(1;6) involved band regions 6q11-13, while two different regions of chromosome 1 (p22, q12-q21) were shown to be translocated to 6q. In reviewing previously published cases of melanoma, an additional two cases of t(1;6) and 13 cases of other translocations to 6q11-13 have been identified. Chromosome 6q contains several biologically important gene sequences including the proto-oncogenes ros, myb, and mas1. However, based on current mapping studies, the breakpoint of this translocation (6q11-13) is not within the region encoding these sequences. By analogy to other systems, molecular analysis of the translocation breakpoints may identify a gene(s) which plays a role in melanoma tumorigenesis.

Entities:  

Mesh:

Year:  1989        PMID: 2642739

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  Chromosome 7 aneusomy. A marker for metastatic melanoma? Expression of the epidermal growth factor receptor gene and chromosome 7 aneusomy in nevi, primary malignant melanomas and metastases.

Authors:  M Udart; J Utikal; G M Krähn; R U Peter
Journal:  Neoplasia       Date:  2001 May-Jun       Impact factor: 5.715

Review 2.  Hereditary melanoma and the search for the melanoma gene.

Authors:  R F Kefford
Journal:  World J Surg       Date:  1992 Mar-Apr       Impact factor: 3.352

3.  AMP kinase-related kinase NUAK2 affects tumor growth, migration, and clinical outcome of human melanoma.

Authors:  Takeshi Namiki; Atsushi Tanemura; Julio C Valencia; Sergio G Coelho; Thierry Passeron; Masakazu Kawaguchi; Wilfred D Vieira; Masashi Ishikawa; Wataru Nishijima; Toshiyuki Izumo; Yasuhiko Kaneko; Ichiro Katayama; Yuji Yamaguchi; Lanlan Yin; Eric C Polley; Hongfang Liu; Yutaka Kawakami; Yoshinobu Eishi; Eishi Takahashi; Hiroo Yokozeki; Vincent J Hearing
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-01       Impact factor: 11.205

4.  Biologic and therapeutic significance of MYB expression in human melanoma.

Authors:  N Hijiya; J Zhang; M Z Ratajczak; J A Kant; K DeRiel; M Herlyn; G Zon; A M Gewirtz
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

5.  A putative marker for human melanoma. A monoclonal antibody derived from the melanoma gene in the Xiphophorus melanoma model.

Authors:  J R Vielkind; V A Tron; B M Schmidt; G J Dougherty; V C Ho; B W Woolcock; B Sadaghiani; C J Smith
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

6.  Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis.

Authors:  S Huang; D Jean; M Luca; M A Tainsky; M Bar-Eli
Journal:  EMBO J       Date:  1998-08-03       Impact factor: 11.598

7.  Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells.

Authors:  Stefano Vavassori; Anil Kumar; Gan Siok Wan; Gundimeda S Ramanjaneyulu; Marco Cavallari; Sary El Daker; Travis Beddoe; Alex Theodossis; Neal K Williams; Emma Gostick; David A Price; Dinish U Soudamini; Kong Kien Voon; Malini Olivo; Jamie Rossjohn; Lucia Mori; Gennaro De Libero
Journal:  Nat Immunol       Date:  2013-07-21       Impact factor: 25.606

8.  Altered chromosome 6 in immortal human fibroblasts.

Authors:  K Hubbard-Smith; P Patsalis; J R Pardinas; K K Jha; A S Henderson; H L Ozer
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

Review 9.  Cytogenetics of human malignant melanoma.

Authors:  J M Trent
Journal:  Cancer Metastasis Rev       Date:  1991-06       Impact factor: 9.264

Review 10.  NUAK2: an emerging acral melanoma oncogene.

Authors:  Takeshi Namiki; Sergio G Coelho; Vincent J Hearing
Journal:  Oncotarget       Date:  2011-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.